This seminar will cover recent research on all deaths due to new psychoactive stimulants in Australia.
This presentation will address mortality due to new psychoactive stimulants and hallucinogens. These cover a wide range of “designer drugs” that have risen to prominence in the 21st century and become a source of clinical concern. They include drugs such as synthetic cathinones and NBOMe.
New data on the characteristics of Australian fatalities, the circumstances of death, and their toxicology will be presented.